COVID patients receiving antibiotics worsened global antimicrobial resistance
Over the course of the pandemic, millions of people around the world have been admitted to hospitals with COVID-19. And, because coronavirus symptoms can be hard to distinguish from pneumonia and other bacterial infections, many of these patients are prescribed broad-spectrum antibiotics.
In a recent published study, researchers with Alberta’s Antimicrobial Resistance (AMR) – One Health Consortium have found this common hospital practice may be acting “as a catalyst” to increase global antimicrobial resistance (AMR).
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
